vs
Side-by-side financial comparison of Acushnet Holdings Corp. (GOLF) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $477.2M, roughly 1.3× Acushnet Holdings Corp.). Royalty Pharma plc runs the higher net margin — 34.4% vs -7.3%, a 41.8% gap on every dollar of revenue. On growth, Acushnet Holdings Corp. posted the faster year-over-year revenue change (7.2% vs 4.8%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -17.9%).
The Acushnet Company is an American company focused on the golf market. The company operates a series of brands that manufacture golf equipment, clothing and accessories.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
GOLF vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $477.2M | $622.0M |
| Net Profit | $-34.9M | $214.2M |
| Gross Margin | 44.1% | — |
| Operating Margin | -3.8% | 62.4% |
| Net Margin | -7.3% | 34.4% |
| Revenue YoY | 7.2% | 4.8% |
| Net Profit YoY | -3027.3% | 2.9% |
| EPS (diluted) | $-0.57 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $477.2M | $622.0M | ||
| Q3 25 | $657.7M | $609.3M | ||
| Q2 25 | $720.5M | $578.7M | ||
| Q1 25 | $703.4M | $568.2M | ||
| Q4 24 | $445.2M | $593.6M | ||
| Q3 24 | $620.5M | $564.7M | ||
| Q2 24 | $683.9M | $537.3M | ||
| Q1 24 | $707.6M | $568.0M |
| Q4 25 | $-34.9M | $214.2M | ||
| Q3 25 | $48.5M | $288.2M | ||
| Q2 25 | $75.6M | $30.2M | ||
| Q1 25 | $99.4M | $238.3M | ||
| Q4 24 | $-1.1M | $208.2M | ||
| Q3 24 | $56.2M | $544.0M | ||
| Q2 24 | $71.4M | $102.0M | ||
| Q1 24 | $87.8M | $4.8M |
| Q4 25 | 44.1% | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 49.2% | — | ||
| Q1 25 | 47.9% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 54.4% | — | ||
| Q2 24 | 54.4% | — | ||
| Q1 24 | 53.4% | — |
| Q4 25 | -3.8% | 62.4% | ||
| Q3 25 | 14.1% | 70.1% | ||
| Q2 25 | 15.2% | 36.3% | ||
| Q1 25 | 16.3% | 94.0% | ||
| Q4 24 | -1.2% | 60.9% | ||
| Q3 24 | 13.2% | — | ||
| Q2 24 | 15.5% | 50.2% | ||
| Q1 24 | 17.2% | -13.0% |
| Q4 25 | -7.3% | 34.4% | ||
| Q3 25 | 7.4% | 47.3% | ||
| Q2 25 | 10.5% | 5.2% | ||
| Q1 25 | 14.1% | 41.9% | ||
| Q4 24 | -0.3% | 35.1% | ||
| Q3 24 | 9.1% | 96.3% | ||
| Q2 24 | 10.4% | 19.0% | ||
| Q1 24 | 12.4% | 0.8% |
| Q4 25 | $-0.57 | $0.49 | ||
| Q3 25 | $0.81 | $0.67 | ||
| Q2 25 | $1.25 | $0.07 | ||
| Q1 25 | $1.62 | $0.55 | ||
| Q4 24 | $0.02 | $0.46 | ||
| Q3 24 | $0.89 | $1.21 | ||
| Q2 24 | $1.11 | $0.23 | ||
| Q1 24 | $1.35 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $618.7M |
| Total DebtLower is stronger | $926.2M | $9.0B |
| Stockholders' EquityBook value | $783.6M | $9.7B |
| Total Assets | $2.3B | $19.6B |
| Debt / EquityLower = less leverage | 1.18× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
| Q4 25 | $926.2M | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $753.1M | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $783.6M | $9.7B | ||
| Q3 25 | $852.3M | $9.6B | ||
| Q2 25 | $808.5M | $9.5B | ||
| Q1 25 | $780.3M | $9.8B | ||
| Q4 24 | $765.2M | $10.3B | ||
| Q3 24 | $863.9M | $10.3B | ||
| Q2 24 | $863.7M | $9.8B | ||
| Q1 24 | $883.7M | $9.9B |
| Q4 25 | $2.3B | $19.6B | ||
| Q3 25 | $2.4B | $19.3B | ||
| Q2 25 | $2.4B | $18.3B | ||
| Q1 25 | $2.4B | $17.6B | ||
| Q4 24 | $2.2B | $18.2B | ||
| Q3 24 | $2.3B | $18.0B | ||
| Q2 24 | $2.3B | $17.7B | ||
| Q1 24 | $2.4B | $16.1B |
| Q4 25 | 1.18× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.98× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-338.0K | $827.1M |
| Free Cash FlowOCF − Capex | $-23.3M | — |
| FCF MarginFCF / Revenue | -4.9% | — |
| Capex IntensityCapex / Revenue | 4.8% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $120.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-338.0K | $827.1M | ||
| Q3 25 | $163.1M | $702.6M | ||
| Q2 25 | $151.9M | $364.0M | ||
| Q1 25 | $-120.3M | $596.1M | ||
| Q4 24 | $-1.1M | $742.5M | ||
| Q3 24 | $144.1M | $703.6M | ||
| Q2 24 | $211.6M | $658.2M | ||
| Q1 24 | $-109.5M | $664.6M |
| Q4 25 | $-23.3M | — | ||
| Q3 25 | $136.9M | — | ||
| Q2 25 | $138.0M | — | ||
| Q1 25 | $-131.5M | — | ||
| Q4 24 | $-33.2M | — | ||
| Q3 24 | $123.7M | — | ||
| Q2 24 | $196.8M | — | ||
| Q1 24 | $-116.8M | — |
| Q4 25 | -4.9% | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 19.2% | — | ||
| Q1 25 | -18.7% | — | ||
| Q4 24 | -7.5% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 28.8% | — | ||
| Q1 24 | -16.5% | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | 3.36× | 2.44× | ||
| Q2 25 | 2.01× | 12.06× | ||
| Q1 25 | -1.21× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 2.56× | 1.29× | ||
| Q2 24 | 2.96× | 6.45× | ||
| Q1 24 | -1.25× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GOLF
| Titleist Golf Equipment | $293.8M | 62% |
| Footjoy Golf Wear | $102.0M | 21% |
| Other | $45.3M | 9% |
| Golf Gear | $36.1M | 8% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
